Forterra PLC (FORT)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 157.40 |
|---|---|
| 52-week range | 126.40 – 200.00 |
| Return, 1 month / 3 months | +13.7% / +14.9% |
| Return, 1 year / 3 years | −12.4% / +21.7% |
| Trend | Uptrend |
| RSI (14) | 62 |
| Volatility (1 year) | 32.7% |
| Worst drawdown (1 year) | -34.4% |
| Average daily value traded | 97.37M GBX |
| Dividend yield | 3.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Forterra is a British manufacturer of building products based in the United Kingdom. It makes clay bricks and a range of concrete products, including blocks, paving, drainage pipes and precast concrete items. Its customers are mainly housebuilders, contractors and merchants in the construction industry, who use these materials in new homes, infrastructure and commercial projects. The company supplies these markets from manufacturing sites across the country.
Forterra PLC trades under the code FORT on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Forterra PLC (FORT) trades on the London Exchange in UK. It last closed at GBX 157.40 on 22 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 1,836 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.4% and over the last three months it rose 14.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 2.3% | ||
| From 52-week high | -19.3% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 14.9% | ||
| 6-month return | -2.9% | ||
| 12-month return, skipping the last month | -23.0% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 32.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.4% | ||
| Liquidity | 89 · Strong | Trades actively. | |
| Average daily value traded | 97.37M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 52 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.8% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +1.9% |
|---|---|
| 1 month | +13.7% |
| 3 months | +14.9% |
| 6 months | −2.9% |
| 1 year | −12.4% |
| 3 years | +21.7% |
| 5 years | −39.9% |
Signals
| 50-day / 200-day average | 145.10 / 153.83 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6.53 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Sep 2026 | GBP 0.0170 |
| 11 Jun 2026 | GBP 0.0430 |
| 18 Sep 2025 | GBP 0.0190 |
| 12 Jun 2025 | GBP 0.0200 |
| 19 Sep 2024 | GBP 0.0100 |
| 13 Jun 2024 | GBP 0.0200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.